ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENTAssignment, Assumption and Amendment Agreement • March 31st, 2022 • Bausch & Lomb Corp • Ophthalmic goods • New Jersey
Contract Type FiledMarch 31st, 2022 Company Industry JurisdictionThis assignment, assumption and amendment agreement (the “Agreement”) is dated January 3, 2022 among Bausch Health Companies Inc., a corporation a corporation incorporated under the British Columbia Business Corporations Act (the “Assignor”), Bausch + Lomb Corporation, a company incorporated under the laws of Canada (the “Assignee”) and Joseph C. Papa (the “Executive”) (the “Parties”, and each a “Party”).
ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENTAssignment, Assumption and Amendment Agreement • March 31st, 2022 • Bausch & Lomb Corp • Ophthalmic goods • New Jersey
Contract Type FiledMarch 31st, 2022 Company Industry JurisdictionThis assignment, assumption and amendment agreement (the “Agreement”) is dated January 3, 2022 among Bausch Health Companies Inc., a corporation a corporation incorporated under the British Columbia Business Corporations Act (the “Assignor”), Bausch + Lomb Corporation, a company incorporated under the laws of Canada (the “Assignee”) and Joseph F. Gordon (the “Executive”) (the “Parties”, and each a “Party”).
ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENTAssignment, Assumption and Amendment Agreement • March 31st, 2022 • Bausch & Lomb Corp • Ophthalmic goods • New Jersey
Contract Type FiledMarch 31st, 2022 Company Industry JurisdictionThis assignment, assumption and amendment agreement (the “Agreement”) is dated January 3, 2022 among Bausch Health Companies Inc., a corporation a corporation incorporated under the British Columbia Business Corporations Act (the “Assignor”), Bausch + Lomb Corporation, a company incorporated under the laws of Canada (the “Assignee”) and Sam Eldessouky (the “Executive”) (the “Parties”, and each a “Party”).